Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
The Secret to Finding the Next Amazon Is Hiding in Plain Sight
03:15am, Wednesday, 01'st Oct 2025
Amazon's success expanding from books to cloud computing has set the benchmark for the ideal growth stock. By putting the customer first and being willing to take risks, Amazon tremendous wealth for i
Hims & Hers Health, Inc. (HIMS) Laps the Stock Market: Here's Why
06:46pm, Monday, 29'th Sep 2025
The latest trading day saw Hims & Hers Health, Inc. (HIMS) settling at $59.12, representing a +1.23% change from its previous close.
3 Healthcare Stocks Using AI to Drive Growth
11:13am, Saturday, 27'th Sep 2025
Artificial intelligence (AI) is transforming the world in much the same way as the adoption of the internet did 30 years ago. This is about more than just search; AI is changing the way many industrie
Hims & Hers: Growth Meets FDA Scrutiny And Tariff Risks
02:06pm, Friday, 26'th Sep 2025
Hims & Hers Health, Inc. has shown strong growth, overcoming partnership fallout and posting a 73% year-over-year revenue surge, but faces execution and regulatory risks. HIMS stock's premium valuatio
Hims & Hers Powers YieldMax's Latest Options-Based Income ETF
01:41pm, Friday, 26'th Sep 2025
YieldMax ETFs grew its expanding lineup of income-oriented funds on Tuesday with the introduction of the YieldMax HIMS Option Income Strategy ETF (NYSE: HIYY).
HIMS vs. DOCS: Which Digital Health Platform Is a Better Investment?
12:06pm, Friday, 26'th Sep 2025
Hims & Hers and Doximity are transforming digital health, but which leads in earnings growth and platform expansion? Let's see.
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Friday, 26'th Sep 2025
Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
A Healthcare Debate: Progyny vs. Hims & Hers
08:05am, Friday, 26'th Sep 2025
In this podcast, Motley Fool analysts Alicia Alfiere, Sanmeet Deo, and Tim Beyers discuss:
Kuehn Law Encourages Investors of Hims & Hers Health, Inc. to Contact Law Firm
02:13pm, Wednesday, 24'th Sep 2025
NEW YORK , Sept. 24, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Hims & Hers Health, Inc. (NYSE: HIMS) breac
I'm Downgrading Hims & Hers Stock
09:37am, Wednesday, 24'th Sep 2025
Hims & Hers Health (HIMS -3.07%) stock is soaring since I rated it a buy.
Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
06:46pm, Tuesday, 23'rd Sep 2025
Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $56, signifying a -2.95% move from its prior day's close.
Hims & Hers Expands Care Ecosystem via Global and Digital Innovation
01:45pm, Monday, 22'nd Sep 2025
HIMS is scaling globally with AI-powered care, new treatments and an $870 million boost to expand its digital ecosystem.
Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy
10:08am, Sunday, 21'st Sep 2025
The financial market is a machine powered by shifting opinions, and when the Federal Reserve announced its latest interest rate cut, those opinions pushed capital into healthcare and financial stocks.
Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties
02:36pm, Friday, 19'th Sep 2025
PHILADELPHIA , Sept. 19, 2025 /PRNewswire/ -- Berger Montague , a national securities litigation law firm, advises shareholders of Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS)
Oscar Health Set For HIMS-Style Moonshot? Shorts Could Burn As ACA Buzz Builds
11:39am, Friday, 19'th Sep 2025
Oscar Health Inc OSCR just became one of Wall Street's buzziest policy trades. With ACA (Affordable Care Act) subsidy chatter swirling ahead of a possible government shutdown, the tech-driven insurer
